PI 3-kinase p55γ, also known as phosphoinositide 3-kinase gamma (PI3Kγ), is a lipid kinase enzyme encoded by the PIK3CG gene in humans. It belongs to the class I PI 3-kinase family and is primarily expressed in leukocytes, where it plays essential roles in various cellular processes, particularly those involved in immune responses and inflammation. As a key mediator of signal transduction, PI3Kγ is activated downstream of G protein-coupled receptors (GPCRs) upon stimulation by extracellular ligands, such as chemokines and growth factors. Its canonical activation pathway involves the recruitment of PI3Kγ to the plasma membrane, where it phosphorylates phosphatidylinositol 4,5-bisphosphate (PIP2) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). This lipid second messenger serves as a docking site for proteins containing pleckstrin homology (PH) domains, such as Akt, leading to their recruitment to the membrane and subsequent activation.
Once recruited to the plasma membrane, activated PI3Kγ promotes the activation of downstream effector molecules involved in diverse cellular processes, including cell survival, proliferation, migration, and cytoskeletal rearrangement. One of the major downstream effectors of PI3Kγ is Akt, also known as protein kinase B (PKB), which, upon activation, phosphorylates various substrates involved in cell growth and survival pathways. Additionally, PI3Kγ activation can modulate the activity of small GTPases such as Rac and Rho, which regulate actin cytoskeleton dynamics and cell migration. Moreover, PI3Kγ-mediated signaling is intricately regulated by various mechanisms, including feedback loops and cross-talk with other signaling pathways, ensuring precise control over cellular responses to extracellular cues. Overall, PI 3-kinase p55γ activation plays a pivotal role in coordinating cellular responses to diverse extracellular stimuli, particularly in immune cells, contributing to normal physiological functions as well as pathological conditions such as inflammation and cancer.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PX-866 | 502632-66-8 | sc-396764 sc-396764A | 1 mg 5 mg | $146.00 $282.00 | ||
PX-866 is an irreversible inhibitor of PI3K, which can lead to alterations in the PI3K/Akt pathway, potentially activating PI 3-kinase p55γ activity. | ||||||
AZD6482 | 1173900-33-8 | sc-364422 sc-364422A | 5 mg 10 mg | $275.00 $390.00 | 1 | |
AZD6482 selectively inhibits the p110β isoform of PI3K, which may indirectly activate the activity of PI 3-kinase p55γ through pathway interactions. | ||||||
PI 3-Kβ Inhibitor VI, TGX-221 | 663619-89-4 | sc-203190 | 1 mg | $437.00 | ||
TGX-221 selectively inhibits the p110β isoform of PI3K, potentially activating PI 3-kinase p55γ activity by influencing the PI3K pathway. | ||||||
IC-87114 | 371242-69-2 | sc-364509 sc-364509A | 5 mg 50 mg | $140.00 $1060.00 | 1 | |
IC-87114 is a selective inhibitor of the p110δ isoform of PI3K, which may activate PI 3-kinase p55γ activity indirectly through PI3K pathway modulation. | ||||||
GDC-0941 | 957054-30-7 | sc-364498 sc-364498A | 5 mg 10 mg | $184.00 $195.00 | 2 | |
Pictilisib, known as GDC-0941, is a broad-spectrum PI3K inhibitor that may indirectly activate PI 3-kinase p55γ activity by targeting the PI3K/Akt pathway. | ||||||
TGR-1202 | 1532533-67-7 | sc-507436 | 25 mg | $286.00 | ||
TGR-1202 is a PI3Kδ inhibitor that can modulate the PI3K pathway, potentially activating PI 3-kinase p55γ activity. | ||||||